Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelics Industry News Stories for the Week of June 1st – 7th, 2020.
Without further ado, let’s get started.
* Yahoo Finance readers, please click here to view full article.
Red White & Bloom TDRYD IPO’d on Friday, and with over $6.5 million in trading volume, it’s clear, investors are taking full advantage of RWB’s temporarily cheap valuation compared to its multi-state operator (MSO) peers.
READ FULL RED WHITE & BLOOM ARTICLE
9. Psychedelics Are Creating a Pathway to Sustainable Addiction Treatment
The path to curing addiction through Psychedelics is becoming more clear and is gaining momentum through more focused treatment. MindMed MMEDF is working with ibogaine to help curb opioid addiction with its 18-MC study and Psychedelic clinic operator AltMed, which was acquired by Champignon Brands SHRMF, will sponsor its network of clinicians and thought leaders throughout R&D campaigns and clinical trials to target addiction as well as several other indications.
READ FULL PSYCHEDELICS THERAPY ARTICLE
8. Magic Mushrooms Pills vs Synthetic Psilocybin: Which is the Better Option?
Psychedelic Counterculture Meets Mainstream Scientific Culture: That’s the Moment We’re in
As we inch closer to legal and regulated Psilocybin, all signs of its ‘Magic Mushroom roots’ will likely fade into the rearview. Could we soon be saying goodbye to piles of stems and caps, and hello to synthetically produced and widely prescribed medication?
7. Illinois Allows Hemp Sales to Medical and Adult-Use Processors
Illinois has expanded its hemp market by allowing hemp producers to sell directly to adult-use and medical cannabis processors in the state.
6. Psychedelics Will See a Boom Much Like Cannabis
Here’s How Entrepreneurs Can Stay Ahead of the Curve
Top business and medical minds in the Psychedelics space, including MindMed MMEDF investors Bruce Linton and Kevin O’Leary as well as Champignon Brands SHRMF CEO Dr. Roger McIntyre agree a growing avenue of opportunity for entrepreneurs in psychedelic medicine is developing.
READ FULL PSYCHEDELICS ARTICLE
5. Gardner: Marijuana Banking Would Pass Senate if Vote Were Held
There’s little doubt in Senator Cory Gardner’s mind that a cannabis banking bill would be approved if it were taken to a full vote of the U.S. Senate, but getting that measure in front of his colleagues has been a slog.
READ FULL CANNABIS BANKING ARTICLE
4. New York Senator Pushes To Legalize Marijuana As Part Of Criminal Justice Package Amid Protests
As mass protests over police killings of black Americans continue across the U.S., there’s a renewed push in New York to pass a package of criminal justice reform legislation that includes marijuana legalization.
3. Michigan Dispensaries Offer Discounts To People With Cannabis-Related Convictions
They Are Calling it the “Redemption Discount”
Three Michigan provisioning centers have teamed up to offer a unique discount program geared specifically toward people caught up in the trap of marijuana prohibition.
2. High Times Expands Retail Footprint, Inks Licensing Deal With Red White & Bloom
Red White & Bloom CEO Brad Rogers Praised the New Partnership
Red White & Bloom Brands TDRYD said Friday it has inked a licensing rights deal with High Times. Under the agreement, RWB is authorized for the branding of High Times medical and recreational dispensaries as well as CBD and THC products in Michigan, Illinois and Florida. RWB also obtained the rights from HT Retail Licensing LLC to use the “Culture” brand of hemp-derived CBD products.
READ FULL RWB HIGH TIMES ARTICLE
1. Here’s What You Need to Know About the Coming Wave of Psychedelics-Based Psychotherapy Clinics
Psychedelics Companies That Own Clinics May Hold the Answer to One of the Top Investor Questions
How will individual firms generate meaningful revenue? As we know, the business of biotech and pharma can be expensive, with potential revenues sometimes years away. For serious investors, here’s why Psychedelic Stocks that own clinics may hold a big advantage over the field.
READ FULL PSYCHEDELIC CLINICS ARTICLE
Photo by Esteban Lopez on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!